Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

0.00%

20.5¢ resapp health limited

Ann: Quarterly Activities Report and Appendix 4C, page-162

First 162 Last

Share
Profile

Follow
razzle7

2,171 Posts.

327

31/10/20

10:09

Post #: 48548774
Share

Originally posted by eason2946: ↑

Hi all,

To say it's a disappointing quarterly it's probably sugar coating it. I'm sure every SH is just as angry as me when we saw the announcement. This is what I think: RAP needs new management/CEO that can sign deals and grow the company fast, period.

It has proven technology that should've been FDA approved, but it failed. And now we're struggling to get it off the ground while TK was campaigning for the 'commercial phase' of RAP. One can argue due to COVID-19 this is making it more difficult, but if that's the case, TK should've been up front about it. Where's the usual company update when we need them? It's only time before some other companies in the industry that'll come up with similar technology and when that happens, RAP will lose its first mover advantage.

I can say I was one of the biggest advocates for RAP. I used to spend spare time doing research about the company & its technology and was genuinely excited by it, as many other SH here were. But it's time we face the reality check: the commercialisation of RAP needs to be better. We need to be able to sell our products and sign deals. We need someone in the front seat that can do that. To me so far, TK has failed.

As posted before, one lesson I learned from years of investing is that never fall in love with a company and only invest how much you are willing to loose. I still have RAP shares but it's only about 30% of what I used to have. I will continue to hold and if the SP drops below my investment plan, I wouldn't hesitate and sell out of RAP and I encourage everyone to do the same.

Lastly, to the usual culprits that downramps here: congrats on pouring gasoline on fire. It's so obvious from day 1 that you only post here for 2 reasons only:

1. RAP is a competitor in the telehealth respiratory industry to your investment and you know it. Perhaps you're being paid by competitor(s) to do that?
2. To prove that you are right and have your daily fight with AlCp.

It's an absolutely disgraceful behaviour to say the least. There's a big difference between posting your view based on research/evidence and posting garbage, wishing other people lose money and unfortunately this is what we see here. I have plenty of other investments and I can say, this is the most coordinated, dedicated downramping attempt I've seen on HC.

Hopefully 2021 will be better for RAP and good luck to all holders.

GLTAH and DYOR

Expand

well ALCP wears two coats one for uo ramping and the second as a big down ramper on PCK,

who paying his bill,is the question

i hold both companies

we need a lot better management,with the upcoming AGM place a big against of the freebies as they need to prove themselves and at this point of time, all we have received bad news over the years and disapointment

they need to do better, but is this the best they can achieve,if so replacement needed

RAP Price at posting: 9.0¢ Sentiment: Hold Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

PYC

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

AW1

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

LGM

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

GRE

Greentech finds lithium trend across 5.5 km at WA's Kobe South